Investigators Hope for Potential Breakthrough in Dual Cellular Therapy Approach for Advanced Tumors
Cellular therapies show promise against solid tumors by overcoming the tumor microenvironment. Roswell Park is conducting a phase 1 trial, OASIS, using CF33-CD19 and blinatumomab to target advanced tumors, aiming to expand immunotherapy's reach beyond traditional treatments.
© Copyright 2025. All Rights Reserved by MedPath